Company Filing History:
Years Active: 2005-2019
Title: Eyal Talor: Pioneering Cancer and Infectious Disease Treatments
Introduction
Eyal Talor, an innovative inventor based in Baltimore, MD, has made significant contributions to the field of biomedical engineering. With a focus on immune response modulation, he holds four patents that reflect his dedication to advancing treatments for cancer and infectious diseases.
Latest Patents
Talor's latest inventions center around peptide constructs intended for the treatment of various diseases. His first patent, a "Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions," involves polypeptides formed by linking multiple peptides derived from different molecules. These constructs are designed to treat or prevent cancer and autoimmune conditions by facilitating the maturation of dendritic cells, which play a crucial role in the immune response. The constructs can significantly enhance immune responses against cancer cells when administered to patients, potentially improving treatment outcomes.
Another notable patent is the "Method for inducing an immune response and formulations thereof," aimed at combating influenza and other infectious diseases. This invention similarly employs peptide constructs to modulate dendritic cell activity, enhancing the body's defense mechanisms. Techniques related to the localization of immune targets further emphasize the practicality and clinical relevance of his research.
Career Highlights
Eyal Talor’s work is primarily associated with CEL-SCI Corporation, a company that focuses on developing innovative immunotherapies. His research has been instrumental in pushing forward the frontiers of treatment options available for serious illnesses. Through his work, he has demonstrated a steadfast commitment to transforming how medical professionals can effectively target cancer and infectious agents.
Collaborations
Throughout his career, Talor has collaborated with esteemed colleagues such as Daniel H. Zimmerman and Kanta Subbarao. These partnerships underscore the collaborative spirit that drives research and innovation in the biomedicine field, allowing for a collective approach to solving complex medical challenges.
Conclusion
Eyal Talor is a remarkable inventor whose contributions to biomedical innovation reflect a deep understanding of immune system dynamics and therapeutic applications. His patents not only open new avenues for treatment but also inspire future research aimed at enhancing patient outcomes in the battle against cancer and infectious diseases.